Biotech · Private company
Axovant Sciences Ltd.
Track this companyFree. Adds Axovant Sciences Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- RVT-101 35 mg tabletsPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- NelotanserinPhase 2 · Dementia With Lewy BodiesClinicalTrials.gov · fetched Nov 12, 2026
- NelotanserinPhase 2 · Lewy Body DementiaClinicalTrials.gov · fetched Nov 12, 2026
- RVT-101 35 mgPhase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RVT-101 35 mgPhase 2 · Dementia With Lewy BodiesClinicalTrials.gov · fetched Nov 12, 2026
- RVT-101 70 mgPhase 2 · Dementia With Lewy BodiesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderPHASE2 · TERMINATED · started Oct 20, 2016ClinicalTrials.gov NCT02871427 · fetched Nov 12, 2026
- Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With DementiaPHASE2 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02910102 · fetched Nov 12, 2026
- 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET ExtensionPHASE3 · TERMINATED · started Apr 26, 2016ClinicalTrials.gov NCT02586909 · fetched Nov 12, 2026
- Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)PHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02708186 · fetched Nov 12, 2026
- Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB StudyPHASE2 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02669433 · fetched Nov 12, 2026